The World Heart Federation Advocacy Team represents the policy interests of our Members at major regional and global health conferences to advocate for improved CVD prevention and control.
The Executive Board (EB) meetings of the WHO are held twice annually, in January/February and May/June. During these meetings, Member States debate pressing global health issues and propose draft resolutions to tackle these problems, which are then submitted for consideration and adoption at the World Health Assembly.
The World Health Assembly (WHA) is the main decision-making and governance body of the WHO, where Member States debate and decide on key global health issues. Taking place in Geneva once a year, its agenda is largely determined by the WHO Executive Board meetings.
The WHO Regional Committee Meetings offer additional key advocacy opportunities. Held annually from August to October, these meetings address pressing health issues specific to each of the six WHO Regions.
At each of these meetings, the WHF Advocacy Team takes the opportunity to make statements on Agenda Items relevant to CVD and NCDs, as well as related topics, such as access to essential medicines and the health of refugees and migrants.
The WHO Executive Board, World Health Assembly and WHO Regional Committee Meetings also gather important health actors and decision-makers together, presenting valuable opportunities to advocate for improved CVD prevention and control at a targeted scale.